Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00716105 · ClinicalTrials.gov registry record · NA

Effect of the Level of Dietary Protein on Infant Growth

A NA study, sponsored by Société des Produits Nestlé (SPN).

Completed
Registry status
NA
Development phase
405
Enrollment target

NCT00716105: Completed NA study, sponsored by Société des Produits Nestlé (SPN).

NCT00716105 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 405 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00716105, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).

COMPLETED
Registry status
NA
Development phase
405 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether infants fed a formula with protein levels different than a standard infant formula have similar growth and development.

Interventions

  • OTHER Standard infant formula
  • OTHER Infant formula with different level of proteins

Trial Details

FieldValue
Enrollment Target 405 participants
Start Date 2008-08
Est. Completion 2015-02
Phase NA

What the finished NCT00716105 record still lists

NCT00716105 is an interventional study that assigns participants to a tested intervention. The registered 405 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard infant formula is the first listed.

NCT00716105 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00716105 about?

NCT00716105 is a clinical study titled "Effect of the Level of Dietary Protein on Infant Growth". The purpose of this study is to determine whether infants fed a formula with protein levels different than a standard infant formula have similar growth and development.

What is the current status of trial NCT00716105?

This trial is currently completed. It is a NA study. The enrollment target is 405 participants. The study started on 2008-08. Estimated completion is 2015-02.

What interventions are being tested in trial NCT00716105?

The interventions under investigation include: Standard infant formula (OTHER), Infant formula with different level of proteins (OTHER).

Who is sponsoring clinical trial NCT00716105?

This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00716105's enrollment target sits among peer trials

405 243rd of 2000 higher than 1,757 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05576350 · 405 participants · NA

    TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk

  • NCT07066657 · 405 participants · Phase 1

    A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

  • NCT06223360 · 406 participants · Phase 2

    A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)

  • NCT06411769 · 406 participants · NA

    Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00716105, the US trial registry maintained by the National Library of Medicine. NCT00716105 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.